APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression

Retrovirology

Volumn 6, Issue , 2009, Pages

  Vázquez Pérez, Joel A ^a   Ormsby, Christopher E ^a   Hernández Juan, Ramón ^a   Torres, Klintsy J ^a   Reyes Terán, Gustavo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; MESSENGER RNA; VIF PROTEIN; APOBEC3G PROTEIN, HUMAN; CYTIDINE DEAMINASE;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; VIREMIA; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MONONUCLEAR CELL; POINT MUTATION; STATISTICS; STOP CODON; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4 LYMPHOCYTE COUNT; CODON, NONSENSE; CYTIDINE DEAMINASE; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; POINT MUTATION; RNA, MESSENGER; STATISTICS AS TOPIC; VIRAL LOAD;

EID: 63549121125     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-23     Document Type: Article

References (29)

1. Sheehy AM Gaddis NC Choi JD Malim MH Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 2002, 418:646-650 10.1038/nature00939 12167863
2. Guo F Cen S Niu M Yang Y Gorelick RJ Kleiman L The interaction of APOBEC3G with HIV-1 nucleocapsid inhibits tRNALys3 annealing to viral RNA J Virol 2007, 81:11322-11331 2045548 17670826 10.1128/JVI.00162-07
3. Li XY Guo F Zhang L Kleiman L Cen S APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription J Biol Chem 2007, 282(44):32065-32074 17855362 10.1074/jbc.M703423200
4. Santiago ML Montano M Benitez R Messer RJ Yonemoto W Chesebro B et al Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection Science 2008, 321:1343-1346 10.1126/ science.1161121 18772436
5. Sheehy AM Gaddis NC Malim MH The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif Nat Med 2003, 9:1404-1407 10.1038/nm945 14528300
6. Yu X Yu Y Liu B Luo K Kong W Mao P et al Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex Science 2003, 302:1056-1060 10.1126/science.1089591 14564014
7. Kao S Khan MA Miyagi E Plishka R Buckler-White A Strebel K The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity J Virol 2003, 77:11398-11407 229358 14557625 10.1128/JVI.77.21.11398-11407.2003
8. Jin X Brooks A Chen H Bennett R Reichman R Smith H APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia J Virol 2005, 79:11513-11516 1193574 16103203 10.1128/ JVI.79.17.11513-11516.2005
9. Cho SJ Drechsler H Burke RC Arens MQ Powderly W Davidson NO APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count J Virol 2006, 80:2069-2072 1367163 16439564 10.1128/JVI.80.4.2069-2072.2006
10. Biasin M Piacentini L Lo CS Kanari Y Magri G Trabattoni D et al Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals J Infect Dis 2007, 195:960-964 10.1086/511988 17330785
11. Ulenga NK Sarr AD Thakore-Meloni S Sankale JL Eisen G Kanki PJ Relationship between Human Immunodeficiency Type 1 Infection and Expression of Human APOBEC3G and APOBEC3F J Infect Dis 2008 18598197
12. Huthoff H Malim MH Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation J Virol 2007, 81:3807-3815 1866099 17267497 10.1128/ JVI.02795-06
13. Russell RA Pathak VK Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F J Virol 2007, 81:8201-8210 1951317 17522216 10.1128/JVI.00395-07
14. Jin X Wu H Smith H APOBEC3G levels predict rates of progression to AIDS Retrovirology 2007, 4:20 1832211 17374143 10.1186/1742-4690-4-20
15. Kaul R Rowland-Jones SL Kimani J Fowke K Dong T Kiama P et al New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers Immunol Lett 2001, 79:3-13 10.1016/S0165-2478(01)00260-7 11595284
16. Stopak KS Chiu YL Kropp J Grant RM Greene WC Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells J Biol Chem 2007, 282:3539-3546 10.1074/jbc.M610138200 17110377
17. Gandhi SK Siliciano JD Bailey JR Siliciano RF Blankson JN The role of APOBEC3G/F-mediated hypermutation in the control of HIV-1 in Elite Suppressors J Virol 2007, 82(6):3125-3130 18077705 2259015 10.1128/ JVI.01533-07
18. Pillai SK Wong JK Barbour JD Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3) Retrovirology 2008, 5:26 2323022 18339206 10.1186/ 1742-4690-5-26
19. Chiu YL Soros VB Kreisberg JF Stopak K Yonemoto W Greene WC Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells Nature 2005, 435:108-114 10.1038/nature03493 15829920
20. Goila-Gaur R Strebel K HIV-1 Vif, APOBEC, and intrinsic immunity Retrovirology 2008, 5:51 2443170 18577210 10.1186/1742-4690-5-51
21. Goila-Gaur R Khan MA Miyagi E Kao S Opi S Takeuchi H et al HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes Virology 2008, 372:136-146 2396953 18023836 10.1016/j.virol.2007.10.017
22. Land AM Ball TB Luo M Pilon R Sandstrom P Embree JE et al HIV-1 Proviral Hypermutation Correlates with CD4 Count in HIV Infected Women from Kenya J Virol 2008, 18(16):8172-8182 18550667 2519552 10.1128/JVI.01115-08
23. Vazquez Perez JA Basualdo Sigales MC Reyes-Teran G Gudino Rosales JC Soler CC Human Immunodeficiency Virus type 1 in seronegative infants born to HIV-1-infected mothers Virol J 2006, 3:52 1524729 16808849 10.1186/1743-422X-3-52
24. R Development Core Team 2008 A language and environment for statistical computing Vienna, Austria 2008
25. Tanaka M Ueno T Nakahara T Sasaki K Ishimoto A Sakai H Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1 Virology 2003, 311:316-325 10.1016/S0042-6822(03)00126-0 12842621
26. Delwart EL Shpaer EG Louwagie J McCutchan FE Grez M Rubsamen-Waigmann H et al Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes Science 1993, 262:1257-1261 10.1126/ science.8235655 8235655
27. Chenna R Sugawara H Koike T Lopez R Gibson TJ Higgins DG et al Multiple sequence alignment with the Clustal series of programs Nucleic Acids Res 2003, 31:3497-3500 168907 12824352 10.1093/nar/gkg500
28. Tamura K Dudley J Nei M Kumar S MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0 Mol Biol Evol 2007, 24:1596-1599 10.1093/molbev/msm092 17488738
29. Rose PP Korber BT Detecting hypermutations in viral sequences with an emphasis on G → A hypermutation Bioinformatics 2000, 16:400-401 10.1093/bioinformatics/16.4.400 10869039